Delivery Order SPE2DB22D9239-SPE2DB25FDM43
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $97,437.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $45,943.92 firm fixed-price delivery order is for the provision of ADCETRIS 50 MG VIALS, a pharmaceutical product, with an ultimate completion date of October 30, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $68,915.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 29, 2025, for the supply of Adcetris 50 mg vials, an oncology medication. The contract carries a ceiling value of approximately $64,054 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was funded by the Defense Logistics Agency's Medical Supply Chain division and includes...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $48,718.74 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $44,728.26, covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 30, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,314.66 contract is for the delivery of ADCETRIS 50 MG VIALS and has a completion date of December 10, 2024. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) worth up to $499,999,999 with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $45,943.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564357709 ADCETRIS 50 MG VIALS. This Delivery Order contract is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $15,314.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which does not have a set-aside designation, is for the delivery of ADCETRIS 50 MG VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDM43Delivery Order
On September 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $113,676.92 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, which carries an ultimate completion date of October 21, 2025, represents a continuation of the company's pharmaceutical supply relationship with the federal government. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its status as a woman-owned small business based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. executes this delivery order under its larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026. This IDC framework enables the DLA to issue task orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a demonstrated track record of fulfilling specialized pharmaceutical deliveries to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $113.7k | 9/29/25 |